Literature DB >> 8836667

Time course of exercise capacity, skeletal and respiratory muscle performance after heart-lung transplantation.

N Ambrosino1, C Bruschi, G Callegari, S Baiocchi, G Felicetti, C Fracchia, C Rampulla.   

Abstract

Recipients of heart-lung transplantation (HLT) show reduced exercise capacity due to several pre- and postsurgical factors. The aim of this study was to evaluate the time course of exercise capacity, and skeletal and respiratory muscle performance in 11 patients (5 females and 6 males; age (mean +/- SD) 38 +/- 13 yrs) undergoing HLT. All of the patients were admitted to our institution for a rehabilitation programme after surgery, and were followed-up for 18 months. On admission, at discharge after an in-patient rehabilitation programme, and every 6 months, patients underwent evaluation of: lung function values; incremental treadmill exercise, 6 min walking distance (6-MWD); maximal inspiratory and expiratory pressures (MIP and MEP, respectively); and peak torque of isokinetic contraction of leg flexor and extensor muscles (IFX and IEX, respectively). On admission, patients had: reduced lung volumes as assessed by vital capacity (VC) (60 +/- 15% of predicted); reduced exercise capacity as assessed by peak oxygen consumption (V'O2,peak) (40 +/- 12% pred); reduced skeletal and respiratory muscle performance as assessed by IEX, IFX (48 +/- 16 and 28 +/- 12 Newton-metres (N x m), respectively) and by MIP and MEP (54 +/- 21 and 58 +/- 19 cmH2O, respectively). Ten patients completed the rehabilitation programme. At discharge, no significant change in dynamic and static lung volumes was observed. However, nonsignificant increases in MIP, MEP, IEX, IFX, 6-MWD and V'O2,peak were recorded. After 6 and 12 months, indices of skeletal and respiratory muscle function and V'O2, peak improved further, but still remained lower than normal values. We conclude that in patients with heart-lung transplantation, skeletal and respiratory muscle function and exercise performance are reduced after surgery, that they may improve with time but are still less than normal after 18 months.

Entities:  

Mesh:

Year:  1996        PMID: 8836667     DOI: 10.1183/09031936.96.09071508

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

Review 1.  Surgery and the respiratory muscles.

Authors:  N M Siafakas; I Mitrouska; D Bouros; D Georgopoulos
Journal:  Thorax       Date:  1999-05       Impact factor: 9.139

Review 2.  Lung transplantation and lung volume reduction surgery versus transplantation in chronic obstructive pulmonary disease.

Authors:  Namrata Patel; Malcolm DeCamp; Gerard J Criner
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 3.  Inspiratory muscle weakness in cardiovascular diseases: Implications for cardiac rehabilitation.

Authors:  Joshua R Smith; Bryan J Taylor
Journal:  Prog Cardiovasc Dis       Date:  2021-10-22       Impact factor: 8.194

4.  Preferential reduction of quadriceps over respiratory muscle strength and bulk after lung transplantation for cystic fibrosis.

Authors:  C Pinet; P Scillia; M Cassart; M Lamotte; C Knoop; C Mélot; M Estenne
Journal:  Thorax       Date:  2004-09       Impact factor: 9.139

5.  Performance in 6-min walk test in prediction of post-operative pulmonary complication in major oncosurgeries: A prospective observational study.

Authors:  Sethu Lekshmi Sathyaprasad; Mary Thomas; Frenny Ann Philip; Km Jagathnath Krishna
Journal:  Indian J Anaesth       Date:  2020-01-07

6.  Orthostatic Hypotension and Concurrent Autonomic Dysfunction: A Novel Complication of Lung Transplantation.

Authors:  Deepika Razia; Sofya Tokman; Sharjeel Israr; Hesham Mohamed; Hesham Abdelrazek; Bhuvin Buddhdev; Ashwini Arjuna; Kendra McAnally; Samad Hashimi; Michael A Smith; Ross M Bremner; Rajat Walia; Ashraf Omar
Journal:  J Transplant       Date:  2022-03-03

Review 7.  Factors contributing to muscle wasting and dysfunction in COPD patients.

Authors:  Rob C I Wüst; Hans Degens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.